Alcon Labs had filed a lawsuit against Perrigo on 14 October 2011 alleging patent infringement.
Patanase (olopatadine hydrochloride) nasal spray helps provide relief from the symptoms of seasonal allergic rhinitis.
Perrigo chairman and CEO Joseph C Papa said the filing marks their investment in new products and expansion of product portfolio.